|
|
Volumn 77, Issue 6, 2001, Pages 441-443
|
|
Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities?
a
b
a
c
d
e
f
f
f
|
|
Author keywords
Antiretroviral therapy; Congenital abnormalities; Folate antagonists
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
FOLIC ACID ANTAGONIST;
ADULT;
ARTICLE;
CONGENITAL MALFORMATION;
FEMALE;
FIRST TRIMESTER PREGNANCY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MAJOR CLINICAL STUDY;
PRENATAL EXPOSURE;
PRIORITY JOURNAL;
RISK FACTOR;
TERATOGENICITY;
ABNORMALITIES, DRUG-INDUCED;
ANTI-HIV AGENTS;
CD4 LYMPHOCYTE COUNT;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLIC ACID ANTAGONISTS;
HIV INFECTIONS;
HUMANS;
INFANT, NEWBORN;
MATERNAL-FETAL EXCHANGE;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PREGNANCY TRIMESTER, FIRST;
RETROSPECTIVE STUDIES;
RISK FACTORS;
|
|
EID: 0035185150
PISSN: 13684973
EISSN: None
Source Type: Journal
DOI: 10.1136/sti.77.6.441 Document Type: Article |
|
Times cited : (45)
|
|
References (10)
|
